ROMPOST 250 mcg Injection for Chronic ITP – Product Details

ROMPOST 250 mcg Injection is a product name associated with a 250 mcg injectable strength. Before publishing, confirm the product’s active ingredient and manufacturer against the approved pack and product insert. If ROMPOST contains romiplostim, it belongs to a class of medicines called thrombopoietin receptor agonists, which help stimulate platelet production.

Romiplostim is used for certain patients with chronic immune thrombocytopenia (ITP), an autoimmune condition in which the immune system destroys platelets. Platelets help blood clot, and low platelet levels can increase the risk of bruising and bleeding. Romiplostim may be prescribed when other treatments have not provided an adequate response.

Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical product information and handles supply enquiries for eligible buyers, subject to product availability, applicable regulations and destination-country import requirements.

Uses of ROMPOST 250 mcg Injection

If the product is confirmed to contain romiplostim, its principal use may include:

Chronic immune thrombocytopenia (ITP): Helps increase platelet production in eligible patients.

Low platelet count management: Supports platelet-count management under specialist medical supervision.

Treatment after inadequate response: May be considered when certain previous ITP treatments have not worked sufficiently.

The medicine is not suitable for every cause of low platelet counts. A qualified haematologist must determine whether treatment is appropriate.

Benefits of ROMPOST 250 mcg Injection

Potential clinical benefits of romiplostim treatment include:

Supports platelet production: Stimulates the body's platelet-producing process.

Helps manage bleeding risk: Maintaining an appropriate platelet count may reduce the risk of clinically significant bleeding in eligible patients.

An additional treatment option: May be considered for patients whose ITP has not responded adequately to other treatments.

Monitored treatment approach: Platelet-count testing helps healthcare professionals adjust treatment according to the patient's response.

Treatment aims to maintain a safe platelet count, not necessarily to normalise it. Individual results vary.

ROMPOST 250 mcg Injection Side Effects

If ROMPOST contains romiplostim, possible side effects include:

Headache and dizziness

Joint or muscle pain

Pain in the arms or legs

Abdominal discomfort or indigestion

Sleep difficulties

Tingling sensations

Important safety information: Romiplostim can increase the risk of blood clots. Seek urgent medical attention for sudden chest pain, breathing difficulty, one-sided leg swelling, or sudden weakness. Platelet counts may also fall after treatment is stopped.

The medicine requires regular blood tests and specialist supervision. It should be administered only as prescribed, following the approved product instructions.

Frequently Asked Questions (FAQs)

1. What is ROMPOST 250 mcg Injection used for?

If it contains romiplostim, it may be prescribed for certain patients with chronic immune thrombocytopenia (ITP) to help increase platelet counts.

2. How does romiplostim work?

Romiplostim activates thrombopoietin receptors, stimulating the bone marrow to produce more platelets.

3. How is ROMPOST 250 mcg Injection administered?

Romiplostim is generally administered as a subcutaneous injection by a qualified healthcare professional. The dose and schedule depend on the patient's weight, platelet count and treatment response.

4. Can ROMPOST be used without a prescription?

No. If it contains romiplostim, it is a prescription medicine requiring appropriate medical assessment and monitoring.

5. How can buyers enquire about ROMPOST 250 mcg Injection?

Hospitals, authorised pharmaceutical distributors and eligible importers can contact Cordium Pharmaceuticals Pvt Ltd to enquire about product availability, documentation, packaging and export requirements.

Enquire About ROMPOST 250 mcg Injection

Cordium Pharmaceuticals Pvt Ltd welcomes genuine pharmaceutical supply enquiries from eligible international buyers. Contact the company to confirm the product identity, available strength, regulatory documentation, pricing and shipping arrangements for your destination market.

Medical disclaimer: This page provides general product information and is not a substitute for professional medical advice. Product indications, availability and import eligibility vary by country. Confirm all product details against the approved prescribing information before use or publication.